Ballast Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-74
| Closed | -$7.02K | – | 173 |
|
|
2024
Q1 | $7.02K | Hold |
74
| – | – | ﹤0.01% | 163 |
|
|
2023
Q4 | $6.61K | Sell |
74
-51
| -41% | -$4.55K | ﹤0.01% | 160 |
|
|
2023
Q3 | $9.13K | Sell |
125
-538
| -81% | -$39.3K | ﹤0.01% | 167 |
|
|
2023
Q2 | $55.2K | Sell |
663
-295
| -31% | -$24.5K | 0.02% | 146 |
|
|
2023
Q1 | $73K | Buy |
958
+219
| +30% | +$16.7K | 0.03% | 144 |
|
|
2022
Q4 | $61.3K | Hold |
739
| – | – | 0.03% | 140 |
|
|
2022
Q3 | $59K | Hold |
739
| – | – | 0.03% | 137 |
|
|
2022
Q2 | $55K | Buy |
739
+17
| +2% | +$1.27K | 0.02% | 141 |
|
|
2022
Q1 | $65K | Sell |
722
-308
| -30% | -$27.7K | 0.03% | 145 |
|
|
2021
Q4 | $115K | Hold |
1,030
| – | – | 0.04% | 130 |
|
|
2021
Q3 | $129K | Sell |
1,030
-39
| -4% | -$4.88K | 0.05% | 124 |
|
|
2021
Q2 | $145K | Hold |
1,069
| – | – | 0.06% | 117 |
|
|
2021
Q1 | $145K | Hold |
1,069
| – | – | 0.07% | 112 |
|
|
2020
Q4 | $150K | Hold |
1,069
| – | – | 0.08% | 104 |
|
|
2020
Q3 | $119K | Hold |
1,069
| – | – | 0.07% | 105 |
|
|
2020
Q2 | $120K | Sell |
1,069
-80
| -7% | -$8.98K | 0.09% | 100 |
|
|
2020
Q1 | $89K | Sell |
1,149
-115
| -9% | -$8.91K | 0.08% | 98 |
|
|
2019
Q4 | $120K | Buy |
+1,264
| New | +$120K | 0.09% | 102 |
|